COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04603690


Column Value
Trial registration number NCT04603690
Full text link
Last imported at : Oct. 27, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

First author
Last imported at : Dec. 12, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Prof. Dr. Ikram Din Ujjan, MBBS, PhD

Contact
Last imported at : Dec. 12, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

ikramujjan@lumhs.edu.pk

Registration date
Last imported at : Oct. 27, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2020-10-27

Recruitment status
Last imported at : March 27, 2022, 4 p.m.
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : Oct. 27, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Oct. 27, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Oct. 27, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Oct. 27, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Open label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : Oct. 27, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : March 27, 2022, 4 p.m.
Source : ClinicalTrials.gov

inclusion criteria: patients must be 18 years of age or older, of either gender patients must be tested positive for sars-cov-2 by rt-pcr within 72 hours prior to enrolment patients must exhibit typical symptoms of covid-19 disease at screening such as fever, fatigue, a dry and contagious cough, loss of appetite, body aches, shortness of breath, mucus or phlegm, sore throat, headache, chills, sometimes with shaking, loss of smell or taste, congestion or runny nose, nausea, or vomiting, diarrhea, muscular pain etc. patients must be in the early stage of covid-19 disease who do not require hospitalization at the time of screening patients must be under the care of a physician for diagnosis of covid-19 patients who have signed informed consent

Exclusion criteria
Last imported at : March 27, 2022, 4 p.m.
Source : ClinicalTrials.gov

patients with proven hypersensitivity or allergic reaction to quercetin or curcumin patients with known chronic kidney disease with estimated creatinine clearance < 50 ml/minute or need for dialysis patients who are severely hypotensive defined as needing hemodynamic pressors to maintain blood pressure patients taking anticoagulant/antiplatelet drugs such as coumarine, heparine, aspirin, clopidrogel, dalteparin, enoxaparin, ticlopidine and warparin. patients with gallstone obstruction hypothyroid suffering patients patients with moderate or severe thrombocytopenia (platelet count <100 ×10⁹/l); pregnant patients

Number of arms
Last imported at : Oct. 27, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : Oct. 27, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Liaquat University of Medical & Health Sciences

Inclusion age min
Last imported at : Oct. 27, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Oct. 27, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

100

Countries
Last imported at : March 27, 2022, 4 p.m.
Source : ClinicalTrials.gov

Pakistan

Type of patients
Last imported at : Oct. 27, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Moderate/severe disease at enrollment

Severity scale
Last imported at : Oct. 27, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

4: Moderate/severe disease at enrollment

Total sample size
Last imported at : March 27, 2022, 4 p.m.
Source : ClinicalTrials.gov

50

primary outcome
Last imported at : March 27, 2022, 4 p.m.
Source : ClinicalTrials.gov

COVID-19 symptoms improvement;SARS-CoV-2 Negativity by RT-PCR

Notes
Last imported at : Oct. 27, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : March 27, 2022, 4 p.m.
Source : ClinicalTrials.gov

Not reported

Arms
Last imported at : March 27, 2022, 4 p.m.
Source : ClinicalTrials.gov

[{"arm_notes": "nan", "treatment_id": 1476, "treatment_name": "Curcumin+quercetin+vitamin d3", "treatment_type": "Vitamins and dietary supplements+others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]